Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Total Non-Current Liabilities: 2022-2025

Historic Total Non-Current Liabilities for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to $609.3 million.

  • Immunocore Holdings' Total Non-Current Liabilities fell 13.42% to $609.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $609.3 million, marking a year-over-year decrease of 13.42%. This contributed to the annual value of $227.2 million for FY2023, which is 22.37% up from last year.
  • Immunocore Holdings' Total Non-Current Liabilities amounted to $609.3 million in Q3 2025, which was down 0.10% from $609.9 million recorded in Q2 2025.
  • Immunocore Holdings' 5-year Total Non-Current Liabilities high stood at $703.8 million for Q3 2024, and its period low was $185.6 million during Q4 2022.
  • In the last 3 years, Immunocore Holdings' Total Non-Current Liabilities had a median value of $609.9 million in 2025 and averaged $576.0 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first rose by 22.37% in 2023, then declined by 13.42% in 2025.
  • Quarterly analysis of 4 years shows Immunocore Holdings' Total Non-Current Liabilities stood at $185.6 million in 2022, then grew by 22.37% to $227.2 million in 2023, then reached $703.8 million in 2024, then decreased by 13.42% to $609.3 million in 2025.
  • Its last three reported values are $609.3 million in Q3 2025, $609.9 million for Q2 2025, and $587.1 million during Q1 2025.